OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36

Immunology Letters

Volumn 137, Issue 1-2, 2011, Pages 15-27

  Xie, ChengHui ^a   Ng, HangPong ^a   Nagarajan, Shanmugam ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

CD36; Inflammation; Macrophages; OxLDL; TLR

Indexed keywords

CD36 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; RANTES; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CELL STRAIN; CELL STRAIN RAW BLUE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FOAM CELL; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD36; CELL LINE; CYTOKINES; FEMALE; INFLAMMATION MEDIATORS; LIPOPROTEINS, LDL; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TOLL-LIKE RECEPTOR 2;

EID: 79954417231     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.01.015     Document Type: Article

References (46)

1. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993, 268:11811-11816.
2. Nicholson A.C., Han J., Febbraio M., Silversterin R.L., Hajjar D.P. Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Ann N Y Acad Sci 2001, 947:224-228.
3. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 2006, 4:211-221.
4. Frieda S., Pearce A., Wu J., Silverstein R.L. Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36. J Biol Chem 1995, 270:2981-2986.
5. Drover V.A., Nguyen D.V., Bastie C.C., Darlington Y.F., Abumrad N.A., Pessin J.E., et al. CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice. J Biol Chem 2008, 283:13108-13115.
6. Ohgami N., Nagai R., Ikemoto M., Arai H., Kuniyasu A., Horiuchi S., et al. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem 2001, 276:3195-3202.
7. Kunjathoor V.V., Tseng A.A., Medeiros L.A., Khan T., Moore K.J. beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins. J Neuroinflammation 2004, 1:23.
8. Moore K.J., El Khoury J., Medeiros L.A., Terada K., Geula C., Luster A.D., et al. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem 2002, 277:47373-47379.
9. Crandall I., Guy R.A., Maguire G.F., Connelly P.W., Kain K.C. Plasmodium falciparum-infected erythrocytes and oxidized low-density lipoprotein bind to separate domains of CD36. J Infect Dis 1999, 180:473-479.
10. Oquendo P., Hundt E., Lawler J., Seed B. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 1989, 58:95-101.
11. Greenberg M.E., Sun M., Zhang R., Febbraio M., Silverstein R., Hazen S.L. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 2006, 203:2613-2625.
12. Fadok V.A., Warner M.L., Bratton D.L., Henson P.M. CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol 1998, 161:6250-6257.
13. Baranova I.N., Kurlander R., Bocharov A.V., Vishnyakova T.G., Chen Z., Remaley A.T., et al. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling. J Immunol 2008, 181:7147-7156.
14. Jimenez-Dalmaroni M.J., Xiao N., Corper A.L., Verdino P., Ainge G.D., Larsen D.S., et al. Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PLoS One 2009, 4:e7411.
15. Silverstein R.L., Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2009, 2:re3.
16. Janabi M., Yamashita S., Hirano K., Sakai N., Hiraoka H., Matsumoto K., et al. activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol 2000, 20:1953-1960.
17. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 2000, 105:1049-1056.
18. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., Andersson L., Koehn S., et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 2002, 277:49982-49988.
19. Moore K.J., Kunjathoor V.V., Koehn S.L., Manning J.J., Tseng A.A., Silver J.M., et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 2005, 115:2192-2201.
20. Kennedy D.J., Kuchibhotla S.D., Guy E., Park Y.M., Nimako G., Vanegas D., et al. Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice. Arterioscler Thromb Vasc Biol 2009, 29:1481-1487.
21. Manning-Tobin J.J., Moore K.J., Seimon T.A., Bell S.A., Sharuk M., Alvarez-Leite J.I., et al. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol 2009, 29:19-26.
22. Moore K.J., Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 2006, 26:1702-1711.
23. El Khoury J.B., Moore K.J., Means T.K., Leung J., Terada K., Toft M., et al. CD36 mediates the innate host response to beta-amyloid. J Exp Med 2003, 197:1657-1666.
24. Medeiros L.A., Khan T., El Khoury J.B., Pham C.L., Hatters D.M., Howlett G.J., et al. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J Biol Chem 2004, 279:10643-10648.
25. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., et al. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527.
26. Stuart L.M., Deng J., Silver J.M., Takahashi K., Tseng A.A., Hennessy E.J., et al. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol 2005, 170:477-485.
27. Bieghs V., Wouters K., van Gorp P.J., Gijbels M.J., de Winther M.P., Binder C.J., et al. Role of scavenger receptor A and CD36 in diet-induced non-alcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology 2010, 138:2477-2486.
28. Liang C.P., Han S., Okamoto H., Carnemolla R., Tabas I., Accili D., et al. Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 2004, 113:764-773.
29. Stewart B.W., Nagarajan S. Recombinant CD36 inhibits oxLDL-induced ICAM-1-dependent monocyte adhesion. Mol Immunol 2006, 43:255-267.
30. Thampi P., Stewart B.W., Joseph L., Melnyk S.B., Hennings L.J., Nagarajan S. Dietary homocysteine promotes atherosclerosis in apoE-deficient mice by inducing scavenger receptors expression. Atherosclerosis 2008, 197:620-629.
31. Kar N.S., Ashraf M.Z., Valiyaveettil M., Podrez E.A. Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36. J Biol Chem 2008, 283:8765-8771.
32. Erdman L.K., Cosio G., Helmers A.J., Gowda D.C., Grinstein S., Kain K.C. CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria. J Immunol 2009, 183:6452-6459.
33. Triantafilou M., Gamper F.G., Haston R.M., Mouratis M.A., Morath S., Hartung T., et al. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 2006, 281:31002-31011.
34. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010, 11:155-161.
35. Pearce S.F., Roy P., Nicholson A.C., Hajjar D.P., Febbraio M., Silverstein R.L. Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. J Biol Chem 1998, 273:34875-34881.
36. Navazo M.D.P., Daviet L., Ninio E., McGregor J.L. Identification on human CD36 of a domain (155-183) implicated in binding low-density lipoproteins (Ox-LDL). Arterioscler Thromb Vasc Biol 1996, 16:1033-1039.
37. Navazo M.D., Daviet L., Savill J., Ren Y., Leung L.L., McGregor J.L. Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem 1996, 271:15381-15385.
38. Daviet L., Craig A.G., McGregor L., Pinches R., Wild T.F., Berendt A.R., et al. Characterization of two vaccinia CD36 recombinant-virus-generated monoclonal antibodies (10/5, 13/10): effects on malarial cytoadherence and platelet functions. Eur J Biochem 1997, 243:344-349.
39. Bodart V., Febbraio M., Demers A., McNicoll N., Pohankova P., Perreault A., et al. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res 2002, 90:844-849.
40. Baranova I.N., Bocharov A.V., Vishnyakova T.G., Kurlander R., Chen Z., Fu D., et al. CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells. J Biol Chem 2010, 285:8492-8506.
41. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14.
42. Hauf N., Goebel W., Fiedler F., Sokolovic Z., Kuhn M. Listeria monocytogenes infection of P388D1 macrophages results in a biphasic NF-kappaB (RelA/p50) activation induced by lipoteichoic acid and bacterial phospholipases and mediated by IkappaBalpha and IkappaBbeta degradation. Proc Natl Acad Sci USA 1997, 94:9394-9399.
43. Flo T.H., Halaas O., Lien E., Ryan L., Teti G., Golenbock D.T., et al. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 2000, 164:2064-2069.
44. Okusawa T., Fujita M., Nakamura J., Into T., Yasuda M., Yoshimura A., et al. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6. Infect Immun 2004, 72:1657-1665.
45. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000, 97:13766-13771.
46. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130:1071-1082.